A subgroup of patients with SSc who exhibit a severe GI phenotype were associated with longer disease duration, ACA positivity, PAH, and worse quality of life.
Every rheumatologist ought to be comfortable in using a validated gastrointestinal symptom scale for evaluation of gastroesophageal reflux disease in patients with scleroderma, Tracy M. Frech, MD, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results